Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension.

Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pharmacology & Therapeutics Pubmed

Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension.

Pharmacology & Therapeutics , Volume 74 (2): 14 – Nov 19, 1997

Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension.

Pharmacology & Therapeutics , Volume 74 (2): 14 – Nov 19, 1997

Loading next page...
 
/lp/pubmed/losartan-an-orally-active-angiotensin-at1-receptor-antagonist-a-review-B0azwUT0HJ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0163-7258
DOI
10.1016/s0163-7258(97)82002-5
pmid
9336021

Abstract

Journal

Pharmacology & TherapeuticsPubmed

Published: Nov 19, 1997

There are no references for this article.